Drugs / SL-BUP
last change Jun 2021 re-read 2 minutes ago

SL-BUP

English name buprenorphine-naloxone
Developed for
substance-related disorder
Investigated by
Columbia University · Harvard Medical School (HMS and HSDM) · Mclean Hospital · NYU Langone Health · National Institute on Drug Abuse (NIDA) · New York State Psychiatric Institute
+1 more · The Emmes Company, LLC

Trials 1 · a red edge is where a trial was stopped

202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04464980 Jun 2021 → Dec 2026 expected substance-related disorder NYU Langone Health Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SL-BUP ClinicalTrials.gov intervention name — accepted as the source's own label NCT04464980